AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05858983 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: FT-001 Mid Dose
Description: Comparison of different dosages of FT-001
Study NCT05858983 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: FT-001 High Dose
Description: Comparison of different dosages of FT-001
Study NCT06515288 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Goes To School (NGTS) Program Intervention Package
Description: The NGTS Program intervention package in this project consists of four components:~1. A comprehensive Nutrition Education to improve healthy eating, physical activity, and hygiene-sanitation practices.~   This is a weekly interactive and fun nutrition and health promotion with different kinds of activities.~2. Healthy School Canteen to improve the availability of healthy food in school. This is an effort to strengthen the school canteen referring to the 4 Pillars of a Healthy School Canteen, including School Commitment and Management, Human Resources, Facilities and Infrastructure, and Food Quality.~3. School Garden. This is a gardening activity as a form of school garden as a media for nutrition education, character building, and contribute to supply vegetables during cooking class sessions in school.~4. Entrepreneurship nutrition. Entrepreneurship nutrition aims to foster entrepreneurial potential and skills among school members in providing healthy food at school.
Study NCT06515288 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Education Capacity Building for Teachers and Management
Description: The intervention schools will receive Nutrition Education Capacity Building for Teachers and School Management, before the above four NGTS components is implemented in the respective school. Three representatives from each school will be invited to attend a 5-day training that include knowledge on adolescent nutrition and health issues, as well as skills in implementing the NGTS Program.
Study NCT05749016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
Description: Inetetamab (Cipterbin) is a newly marketed anti-HER2 monoclonal antibody with amino acid modified Fc region and enhanced antibody-dependent cellular cytotoxicity (ADCC) effect. There was no robust evidence evaluating the combination of inetetamab with pertuzumab and neoadjuvant chemotherapy (paclitaxel + carboplatin) in the neoadjuvant setting. This study aimed to evaluate the efficacy and safety of inetetamab + pertuzumab+paclitaxel + carboplatin (TCbIP) as a neoadjuvant chemotherapy regimen in the treatment of patients with locally advanced HER2-positive breast cancer.
Study NCT05637983 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: US-guided femoral puncture vs Fluoroscopy-guided puncture
Description: US-guided femoral puncture and Perclose ProGlide®/Prostyle implantation compared to Fluoroscopy-guided puncture and Perclose ProGlide®/Prostyle in TAVR
Study NCT05637983 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: US-guided femoral puncture vs Fluoroscopy-guided puncture
Description: US-guided femoral puncture and Perclose ProGlide®/Prostyle implantation compared to Fluoroscopy-guided puncture and Perclose ProGlide®/Prostyle in TAVR
Study NCT05287815 — intervention group
Intervention type: BEHAVIORAL
Intervention: training/observation
Description: In the study, elderly individuals who met the sampling criteria and accepted to participate in the study were 30 in the experimental group and 30 in the control group, using the stratified randomization method to control and balance the effects of age (65-75 years, 76 and over) and gender (female and male) variables. It will be planned to be an elderly individual. Computer-assisted randomization, which is one of the simple randomization methods, was assigned to the groups according to the determined.
Study NCT04646382 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Garlic and onion concentrate
Description: Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).
Study NCT04646382 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Garlic and onion concentrate
Description: Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).
Study NCT04646382 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Microcrystalline cellulose
Study NCT04646382 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Control
Description: Microcrystalline cellulose
Study NCT06088589 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mismatch negativity
Description: Event related potentials are compared between frequent and infrequent speech sounds (i.e., ba vs da).
Study NCT06467695 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BIOPAC Stimsola
Description: Transcranial Electrical Stimulator
Study NCT06467695 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: BIOPAC Stimsola Sham (zero amps)
Description: Transcranial Electrical Stimulator set to 0 amps
Study NCT06417970 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Shoulder Proprioception, Palmar Touch Sensation and Psychometric Parameters
Description: Shoulder Proprioception: Proprioception will be measured with isokinetic device. The measurement reference angles are 30° and 60°.~Palmar Touch Sensation: Palmar tactile sensation will be measured with the Semmes-Weinstein Monofilament.~Psychometric Parameters: Athlete Psychological Strain Questionnaire, Tampa kinesiophobia questionnaire
Study NCT06305663 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bausch + Lomb (kalifilcon A) Myopia Control Soft (Hydrophilic)
Description: Bausch + Lomb (kalifilcon A) Myopia Control Soft (Hydrophilic)
Study NCT06305663 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CooperVision MiSight (omafilcon A/60%) Myopia Control one day Soft Contact Lens
Description: CooperVision MiSight (omafilcon A/60%) Myopia Control one day Soft Contact Lens
Study NCT05689359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Description: Hydroxychloroquine will be administered at 600 mg po BID for 3 days prior to starting chemotherapy, continued during the course of chemotherapy, and for 7 days after chemotherapy.
Study NCT05959928 — intervention group
Intervention type: DEVICE
Intervention: Continuous wearable thermometer placed on patient's armpit to monitor body temperature remotely
Description: The HaH team will place Viture Device on the patient's armpit and train the patient and/or caregiver. They will ask to complete control STMs between 3 and 6 times a day on the same arm where the Viture Device is placed and record the measuring data in the Home data collection notebook (HDCN)
Study NCT05625243 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bulk-fill ormocer (Admira fusion x-tra, Voco, Cuxhaven, Germany) with Precontoured circumferential matrix system (Palodent 360, Dentsply Caulk, Millford DE, USA)
Description: A suitable size precontoured circumferential matrix band (Palodent 360, Dentsply Caulk, Millford DE, USA) will be selected and placed. Teeth separation will be acquired with a suitable size wedge (Palodent V3, Dentsply Caulk, Millford DE, USA) and a separation ring (Palodent V3 universal ring, Dentsply Caulk, Millford DE, USA). Then the bulk-fill ormocer (Admira fusion x-tra, Voco, Cuxhaven, Germany) will be applied and light cured according to the manufacturer instructions.
Study NCT05625243 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bulk-fill ormocer (Admira fusion x-tra, Voco, Cuxhaven, Germany) with Precontoured circumferential matrix system (Palodent 360, Dentsply Caulk, Millford DE, USA)
Description: A suitable size precontoured circumferential matrix band (Palodent 360, Dentsply Caulk, Millford DE, USA) will be selected and placed. Teeth separation will be acquired with a suitable size wedge (Palodent V3, Dentsply Caulk, Millford DE, USA) and a separation ring (Palodent V3 universal ring, Dentsply Caulk, Millford DE, USA). Then the bulk-fill ormocer (Admira fusion x-tra, Voco, Cuxhaven, Germany) will be applied and light cured according to the manufacturer instructions.
Study NCT05625243 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bulk-fill ormocer (Admira fusion x-tra, Voco, Cuxhaven, Germany) with Precontoured sectional matrix systym (Saddle matrix, TORVM, Moscow, Russia)
Description: A suitable size precontoured sectional matrix band (Saddle matrix, TORVM, Moscow, Russia) will be selected and placed. Teeth separation will be acquired with a suitable size wedge (fixing wooden wedges, TORVM, Moscow, Russia) and a separation ring (Delta ring, TORVM, Moscow, Russia). Then the bulk-fill ormocer (Admira fusion x-tra, Voco, Cuxhaven, Germany) will be applied and light cured according to the manufacturer instructions.
Study NCT05625243 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bulk-fill ormocer (Admira fusion x-tra, Voco, Cuxhaven, Germany) with Precontoured sectional matrix systym (Saddle matrix, TORVM, Moscow, Russia)
Description: A suitable size precontoured sectional matrix band (Saddle matrix, TORVM, Moscow, Russia) will be selected and placed. Teeth separation will be acquired with a suitable size wedge (fixing wooden wedges, TORVM, Moscow, Russia) and a separation ring (Delta ring, TORVM, Moscow, Russia). Then the bulk-fill ormocer (Admira fusion x-tra, Voco, Cuxhaven, Germany) will be applied and light cured according to the manufacturer instructions.
Study NCT05625243 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bulk-fill resin composite (X-tra fill, Voco, Cuxhaven, Germany) with Precontoured circumferential matrix system (Palodent 360, Dentsply Caulk, Millford DE, USA)
Description: A suitable size precontoured circumferential matrix band (Palodent 360, Dentsply Caulk, Millford DE, USA) will be selected and placed. Teeth separation will be acquired with a suitable size wedge (Palodent V3, Dentsply Caulk, Millford DE, USA) and a separation ring (Palodent V3 universal ring, Dentsply Caulk, Millford DE, USA). Then the bulk fill resin composite (X-tra fill, Voco, Cuxhaven, Germany) will be applied and light cured according to the manufacturer instructions.
Study NCT05625243 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bulk-fill resin composite (X-tra fill, Voco, Cuxhaven, Germany) with Precontoured circumferential matrix system (Palodent 360, Dentsply Caulk, Millford DE, USA)
Description: A suitable size precontoured circumferential matrix band (Palodent 360, Dentsply Caulk, Millford DE, USA) will be selected and placed. Teeth separation will be acquired with a suitable size wedge (Palodent V3, Dentsply Caulk, Millford DE, USA) and a separation ring (Palodent V3 universal ring, Dentsply Caulk, Millford DE, USA). Then the bulk fill resin composite (X-tra fill, Voco, Cuxhaven, Germany) will be applied and light cured according to the manufacturer instructions.
Study NCT05695703 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Strength Training Group
Description: The participants of experimental group will perform core strength training regime for 6 weeks (3 days per week). Each exercise session will last for a period of 45 mins, the exercises would be performed in 3 sets of 5 repetitions with 5 seconds hold time and 10 seconds rest between each repetition and a minutes rest in between each set.~Following exercises would be performed :~Bridge, Crunch, Plank, Side Plank, Mountain Climb.
Study NCT05695703 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Training Group
Description: The participants of conventional group will perform following exercises :~Running (10 repetitions X 3 sets), Jogging (10 repetitions X 3 sets), Stretching (10 repetitions X 3 sets)~Rest between Exercises : 10-15 Seconds Rest between Set of Exercises : 30-60 Seconds Cricketers will receive exercises for 8 weeks. There will be 3 sessions per week.
Study NCT05447273 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Multi-parametric, functional magnetic resonance imaging (MRI)
Description: Multi-parametric, functional magnetic resonance imaging (MRI) will be performed in all included patients prior to surgery.
Study NCT06441409 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Description: Patients were intervened with lifestyle only and returned to clinic for tests in 6 months.~Lifestyle intervention included the diet and exercise. Diet was an energy-restricted balanced diet. Exercise requires 5 days a week and 30 minutes every day.
Study NCT06416631 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: artificial intelligence based screw planning
Description: artificial intelligence technology helps to plan screws in robot assisted spinal surgery
Study NCT06416631 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: manually screw planning
Description: the screw trajcetories are manually planned
Study NCT06105606 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AveCure Flexible Microwave Ablation Probe
Description: Consists of a handheld, surgical device which delivers microwave energy from its microwave antenna. The flexible probe has a 3cm active microwave field that radiates from the tip.
Study NCT06443294 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking cessation video series.
Description: The intervention in this study is a series of six videos totally approximately 40 minutes. These videos are led by a doctoral psychology student with experience in working with tobacco smokers. Videos utilize empirically-supported strategies for smoking cessation.
Study NCT05882929 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Watching Cartoons
Description: The cartoon will be watched after the child comes to the service after the operation and the postoperative period is prepared (taking the vital signs, putting on the clothes, controlling the bleeding, telling the feeding time, etc.).
Study NCT05882929 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ball spin
Description: ball squeezing will be applied after the child comes to the service after the operation and after the postoperative period preparation is made (taking the vital signs, dressing the clothes, controlling the bleeding, telling the feeding time, etc.).
Study NCT06419491 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Partner notification by a trained counsellor
Description: One (or more if needed) interview with a partner notification trained counsellor is offered to index patients. During the interview, the counsellor gives information on partner notification, helps the index patients to remember their partners, to assess their HIV/sexually transmitted infection exposure and explains options to notify them.~During the interview, the index patient can choose to entrust the notification of some of their partners to the counsellor. However, according to French law, provider referral is permitted only when it is anonymous. Therefore, this option is reserved to partners with a lot of partners in order to limit the risk of identifying the index patient
Study NCT04644029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Islatravir
Description: Oral 60 mg tablet administered once monthly during Part 1.
Study NCT04644029 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to FTC/TDF
Description: 0 mg tablet administered once daily during Part 1.
Study NCT04644029 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FTC/TDF
Description: Each tablet contains 200 mg emtricitabine and 245 mg of tenofovir disoproxil (equivalent to 300 mg tenofovir disoproxil fumarate or 201.22 mg tenofovir disproxil phosphate), administered orally once daily in Parts 1, 2, and 3.
Study NCT04644029 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo to ISL
Description: 0 mg tablet administered orally once monthly in Part 1.
Study NCT04531865 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Rituximab
Description: Rituximab: 375 mg/m2 intravenously on day 0 and day 7
Study NCT04531865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab: 375 mg/m2 intravenously on day 0 and day 7
Study NCT04531865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate Mofetil
Description: Addition of Maintenance Mycophenolate Mofetil from 4 Month onwards. Dose: 20\~30mg/kg/day，BID. Total duration : 8 months.
Study NCT04531865 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablets matching Mycophenolate Mofetil
Description: Addition of Maintenance Placebo tablets matching Mycophenolate Mofetil from 4 Month onwards. Dose: 20\~30mg/kg/day，BID. Total duration : 8 months.
Study NCT05158621 — intervention group
Intervention type: PROCEDURE
Intervention: blood collection for research (next generation sequencing [NGS])
Description: participants will have whole blood collected for NGS
Study NCT05158621 — intervention group
Intervention type: PROCEDURE
Intervention: blood collection for research (HLA typing)
Description: participants will have whole blood collected for HLA typing
Study NCT05158621 — intervention group
Intervention type: PROCEDURE
Intervention: blood collection for research (circulating tumor DNA [ctDNA])
Description: participants will have whole blood collected for ctDNA detection
Study NCT05469646 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1819479
Description: BI 1819479
Study NCT05469646 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching placebo
Description: Matching placebo
Study NCT04789304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1595043
Description: BI 1595043
Study NCT04789304 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT04789304 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Midazolam
Study NCT04789304 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Midazolam
Description: Midazolam
Study NCT05453136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TS-142 5 mg
Description: Participants received repeated doses of 5 mg of TS-142 (oral tablet)
Study NCT05453136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TS-142 10 mg
Description: Participants received repeated doses of 10 mg of TS-142 (oral tablet)
Study NCT05453136 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to TS-142
Description: Participants received repeated doses of placebo to TS-142 (oral tablet)
Study NCT05552196 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod
Description: Ponesimod tablet will be administered orally.
Study NCT05552196 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Description: Carbamazepine tablet will be administered orally.
Study NCT05198895 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Near-infrared (NIR)
Description: NIR spectral assessment of glycated nail keratin vs glycated haemoglobin (HbA1c)
Study NCT04341935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linagliptin
Description: 5 mg Linagliptin administered by mouth once daily
Study NCT04341935 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin regimen
Description: Standard of care insulin regimen as per hospital protocol
Study NCT04718922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorhexidine Gluconate 0.12 % Mouthwash
Description: Intervention with chlorhexidine mouthrinse will be performed approximately 10 min before the start of EBUS-TBNA
Study NCT06429904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nimotuzumab+ NALIRIFOX
Description: Drug: Nimotuzumab Patients will receive Nimotuzumab 400 mg weekly or Nimotuzumab 600mg, 600mg, 400mg on Day 1, 8, 15, respectively, 28 days as a cycle, up to 6 cycles.~Other Names: h-R3~Drug: NALIRIFOX Patients will receive NALIRIFOX (liposomal irinotecan 50 mg/m2, oxaliplatin 60 mg/m2, leucovorin 400 mg/m2, and fluorouracil 2400 mg/m2, administered sequentially as a continuous intravenous infusion over 46 h) on days 1 and 15 of a 28-day cycle, up to 6 cycles.~Other Names: NALIRIFOX
Study NCT06257732 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The exercise interventions in this study include High-Intensity Interval Training (HIIT), involving brief bursts of intense exercise; Resistance Exercise, focusing on strength and muscle endurance; and Fatmax Exercise, tailored to optimize fat oxidation during aerobic activity.
Study NCT06257732 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: Motivational Interviewing will be employed as a counseling technique to elicit behavior change by fostering collaborative and empathetic conversations, enhancing motivation for positive lifestyle modifications in individuals with liver fat accumulation.
Study NCT05029661 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Carotid ultrasound
Description: * Ultra-COMPASS measurements (longitudinal + cross-sectional) Shear wave elastography: plaque stiffness Strain elastrogaphy: plaque deformation B-mode visualization: geometry~* Intima-media thickness~* Pulse wave velocity
Study NCT05319548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Purple-Red Carrot Juice
Description: Purple-Red carrot juice contains provitamin A carotenoids (beta-carotene, alpha-carotene), the non-provitamin A carotenoid, lycopene, as well as anthocyanins
Study NCT05319548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Red Carrot Juice
Description: Red carrot juice contains provitamin A carotenoids (beta-carotene, alpha-carotene), and the non-provitamin A carotenoid, lycopene, but does NOT contain anthocyanins..
Study NCT05319548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Purple Carrot Juice
Description: Purple carrot juice does NOT contain provitamin A carotenoids (beta-carotene, alpha-carotene), nor the non-provitamin A carotenoid, lycopene, but contains anthocyanins.
Study NCT06293742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ECC5004
Description: ECC5004 tablet will be administered orally.